Literature DB >> 4364934

Vincristine neurotoxicity.

S Rosenthal, S Kaufman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4364934     DOI: 10.7326/0003-4819-80-6-733

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  42 in total

Review 1.  Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects.

Authors:  P G Bain; P L Lantos; V Djurovic; I West
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Vincristine-induced neuropathy in rat: electrophysiological and histological study.

Authors:  Feras M H Ja'afer; Farqad B Hamdan; Faiq H Mohammed
Journal:  Exp Brain Res       Date:  2006-05-31       Impact factor: 1.972

4.  Vindesine. A short review of preclinical and first clinical data.

Authors:  R W Dyke; R L Nelson; W P Brade
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 5.  Vincristine neurotoxicity. Pathophysiology and management.

Authors:  S S Legha
Journal:  Med Toxicol       Date:  1986 Nov-Dec

Review 6.  Chemotherapy-induced peripheral neuropathy: A current review.

Authors:  Nathan P Staff; Anna Grisold; Wolfgang Grisold; Anthony J Windebank
Journal:  Ann Neurol       Date:  2017-06-05       Impact factor: 10.422

7.  Vincristine induced neurotoxicity in cancer patients.

Authors:  Sunil Gomber; Pooja Dewan; Devender Chhonker
Journal:  Indian J Pediatr       Date:  2010-01       Impact factor: 1.967

8.  Vincristine-induced recurrent laryngeal nerve paralysis in children.

Authors:  J D Tobias; P M Bozeman
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

9.  Multiple impairments of cutaneous nociceptor function induced by cardiotoxic doses of Adriamycin in the rat.

Authors:  Krisztina Boros; Gábor Jancsó; Mária Dux; Zoltán Fekécs; Péter Bencsik; Orsolya Oszlács; Márta Katona; Péter Ferdinandy; Antal Nógrádi; Péter Sántha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-06-24       Impact factor: 3.000

10.  Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma.

Authors:  S Koeppen; C C P Verstappen; R Körte; M E Scheulen; D Strumberg; T J Postma; J J Heimans; P C Huijgens; B Kiburg; K Renzing-Köhler; H C Diener
Journal:  J Cancer Res Clin Oncol       Date:  2004-01-16       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.